Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.50 |
| ▸ | ADH1B | P00325 | 2/20 | 0.50 |
| ▸ | ADH1C | P00326 | 2/20 | 0.50 |
| ▸ | ADH1A | P07327 | 2/20 | 0.50 |
| ▸ | ADH7 | P40394 | 2/20 | 0.50 |
| ▸ | ADH4 | P08319 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | KDM1A | O60341 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4552203 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7534332 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7540736 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7539638 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7540762 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL817870 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7533182 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7535052 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL3261321 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C | |
| SCHEMBL7534941 | 1.00 | TSHR (0.55) | TSHRALDH1A1EPHX1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-10-26 | — | — | US | claimed |
| EP-3221374-A1 | MOISTURE CURABLE COMPOSITIONS | Momentive Performance Materials Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| WO-2016081790-A1 | MOISTURE CURABLE COMPOSITIONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2016-05-26 | — | — | WO | claimed |
| EP-0513300-B1 | QUATERNARY CROSSLINKED ALLYLAMMONIUMPOLYMERS, PREPARATION AND USE THEREOF | ZENECA LTD (GB) | 1997-05-14 | — | — | EP | claimed |
| US-5589166-A | Cross-linked quaternary ammonium derivatives of poly(N,N-dialkylallyl) ammonium polymers | ZENECA LIMITED (GB) | 1996-12-31 | — | — | US | claimed |
| US-5462730-A | Anticholesterol agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1995-10-31 | — | — | US | claimed |
| EP-0513300-A1 | QUATERNARY CROSSLINKED ALLYLAMMONIUMPOLYMERS, PREPARATION AND USE THEREOF. | ICI PLC (GB) | 1992-11-19 | — | — | EP | claimed |
| WO-1992010522-A1 | QUATERNARY CROSSLINKED ALLYLAMMONIUMPOLYMERS, PREPARATION AND USE THEREOF | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-06-25 | — | — | WO | claimed |
| US-4644042-A | USING WATER SOLUBLE FREE RADICAL POLYMERIZATION CATALYST | NITTO BOSEKI CO., LTD. (JP) | 1987-02-17 | — | — | US | claimed |
| EP-0173963-A2 | Polymers of n-substituted secondary monoallylamines and their salts and process for producing the same | NITTO BOSEKI CO., LTD. (JP) | 1986-03-12 | — | — | EP | claimed |
| CN-115605529-B | Photochromic polydiorganosiloxane vinyl cross-linking agent | 爱尔康公司 | 2024-03-26 | — | — | CN | disclosed |
| US-20230407133-A1 | CURABLE SILICONE COATING COMPRISING A NON-ORGANO TIN CATALYST | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-12-21 | — | — | US | disclosed |
| CN-116888193-A | Polysiloxane vinyl cross-linking agent with high refractive index | 爱尔康公司 | 2023-10-13 | — | — | CN | disclosed |
| EP-4255981-A1 | CURABLE SILICONE COATING COMPRISING A NON-ORGANO TIN CATALYST | Momentive Performance Materials Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| CN-116802227-A | Curable silicone coating comprising non-organotin catalyst | 迈图高新材料公司 | 2023-09-22 | — | — | CN | disclosed |
| EP-0513300-A1 | QUATERNARY CROSSLINKED ALLYLAMMONIUMPOLYMERS, PREPARATION AND USE THEREOF. | ICI PLC (GB) | 1992-11-19 | — | — | EP | disclosed |
| WO-1992010522-A1 | QUATERNARY CROSSLINKED ALLYLAMMONIUMPOLYMERS, PREPARATION AND USE THEREOF | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-06-25 | — | — | WO | disclosed |
| US-4644042-A | USING WATER SOLUBLE FREE RADICAL POLYMERIZATION CATALYST | NITTO BOSEKI CO., LTD. (JP) | 1987-02-17 | — | — | US | disclosed |
| EP-0196588-A2 | Process for the preparation of copolymers of N-substituted secondary monoallylamines or salts thereof | NITTO BOSEKI CO., LTD. (JP) | 1986-10-08 | — | — | EP | disclosed |
| EP-0173963-A2 | Polymers of n-substituted secondary monoallylamines and their salts and process for producing the same | NITTO BOSEKI CO., LTD. (JP) | 1986-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170306096-A1 | MOISTURE CURABLE COMPOSITIONS | DOT1L, EHMT2, CDH1 | TSHR 4580/4885ALDH1A1 595/4885EPHX1 993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.